SUNNYVALE, Calif., March 31, 2016 -- Agylytyx management talked publicly about financial results for FY2015 today. The results revealed that the company turned in strong year-over-year revenue growth and significantly beat its earnings plan for the year. Management noted that the company’s better than expected performance enabled it to make investments designed to continue the company’s momentum into 2016.
Revenue more than doubled year over year. Ten percent of the company’s 2015 revenue was from its product subscription business which started in April. The company expects that to double in 2016 to twenty percent of revenue.
Management indicated that profits in 2015 had been reinvested toward the end of the year. Madison Laird, the company’s CEO, noted: “we made a strategic decision that our best cost of capital option was to invest our profits back into the company.” He continued “reinvesting our profits in Q4 allowed us to exceed our sales forecast for the year and enter 2016 with an even stronger sales pipeline.”
The company also made infrastructure investments in the second half of the year. These investments were predicted in the company’s mid-year earnings press release. They enabled Agylytyx to more quickly deploy customers and also enhanced the company’s product roadmap.
About Agylytyx
Agylytyx provides cloud-based enterprise business analytic software. The company's flagship product, the Agylytyx Generator, frees up analyst time and results in better decision making across corporations. Agylytyx is based in Sunnyvale, California, and has locations in Philadelphia and Washington D.C. For more information about Agylytyx visit www.agylytyx.com.
Scott Gripenstraw [email protected] (408) 498-5840


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Instagram Outage Disrupts Thousands of U.S. Users
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



